Latest filing published 24 May 2023 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
George M Milne: trading record in brief
All filings by George M Milne on record concern Aurinia Pharmaceuticals Inc. The record holds 7 filings, for trades running from 8 May 2017 to 18 May 2023.
Every open-market trade on record is a purchase: 5 purchases worth €410k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 option exercise. So far in 2023, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €43k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.
Most recently, on 24 May 2023, the filings show an option exercise in Aurinia Pharmaceuticals Inc. The last insider purchase was made public on 7 March 2023, 1,344 days ago. Typically, a trade is published a median of 5 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to George M Milne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,733 sharesCommon SharesTSXSEDI:4132974
- 20,000 shares@ CA$8.914250.7% of flowCommon SharesTSXSEDI:4090012Canonical exit: 31 May 2023 (T+90)
- 5,000 shares@ CA$13.0035.8% of flowCommon SharesTSXSEDI:3700891Canonical exit: 3 Jun 2021 (T+90)
- 20,000 shares@ CA$13.1038Common SharesTSXSEDI:3647581Canonical exit: 21 Mar 2021 (T+90)
- 10,000 shares@ CA$4.96100.0% of flowCommon SharesTSXSEDI:3440505Canonical exit: 14 Jan 2020 (T+90)
- Common SharesTSXSEDI:3395645
- 10,000 shares@ CA$6.320135.9% of flowCommon SharesTSXSEDI:3395646Canonical exit: 6 Oct 2019 (T+90)
7 of 7 declarations
